The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Zecotek Photonics Inc

Venture: ZMS
Delayed quote

$0.46

Today's change+0.04 +8.24%
Updated July 31 3:59 PM EDT. Delayed by at least 15 minutes.
 

Zecotek Photonics Inc

Venture: ZMS
Delayed quote

$0.46

Today's change+0.04 +8.24%
Updated July 31 3:59 PM EDT. Delayed by at least 15 minutes.

Zecotek Photonics Inc Hits New 20-day High

Zecotek Photonics Inc closed up sharply Friday, rallying $0.04 or 8.24% to $0.46 and setting a new 20-day high. Over the last five days, shares have gained 27.78% and 10.84% year to date. Shares have underperformed the S&P TSX by 17.13% during the last year.

Key company metrics

  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS-$0.10
Updated July 31 3:59 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-3,659.39%

Zecotek Photonics Inc has a net profit margin of -3,659.39%. Besides being negative, it is also below the industry average and implies that this company is not effective at turning revenues into bottom line profit.
Company Books

S&P TSX0.60%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2015Q2/2015Q1/2015Q4/2014
Fiscal Quarter Endvalues in $ millions unless otherwise notedApr 30, 201504/30/2015Jan 31, 201501/31/2015Oct 31, 201410/31/2014Jul 31, 201407/31/2014
Revenue0000
Total other revenue--------
Total revenue0000
Gross profit--------
Total cost of revenue--------
Total operating expense1224
Selling / general / administrative1223
Research & development0001
Depreciation / amortization0000
Interest expense (income), net operating--------
Unusual expense (income)------0
Other operating expenses, total--------
Operating income-1-2-2-4
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-1-2-2-4
Income after tax-1-2-2-4
Income tax, total--------
Net income-1-2-2-4
Total adjustments to net income--------
Net income before extra. items-1-2-2-4
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-1-2-2-4
Inc. avail. to common incl. extra. items-1-2-2-4
Diluted net income-1-2-2-4
Dilution adjustment--------
Diluted weighted average shares1121109999
Diluted EPS excluding extraordinary itemsvalue per share-0.01-0.02-0.02-0.04
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share-0.01-0.02-0.02-0.04